AHA 2025 highlights included new guidelines and targeted approaches advancing heart failure and cardiovascular care. Our top coverage from this year’s American Heart Association (AHA) 2025 Scientific ...
IBI3016 demonstrates sustained and potent AGT mRNA suppression with preliminary evidence of antihypertensive efficacy after single-dose subcutaneous administration. The clinical Phase 1 data of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback